DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Jones JA, Mato AR, Wierda WG. et al.
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial.
Lancet Oncol 2018;
19: 65-75
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.